NATIXIS ADVISORS, L.P. - HUTCHISON CHINA MEDITECH LTD ownership

HUTCHISON CHINA MEDITECH LTD's ticker is HCM and the CUSIP is 44842L103. A total of 123 filers reported holding HUTCHISON CHINA MEDITECH LTD in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of HUTCHISON CHINA MEDITECH LTD
ValueSharesWeighting
Q1 2022$206,000
-65.0%
10,889
-35.2%
0.00%
-50.0%
Q4 2021$589,000
+1.0%
16,794
+5.5%
0.00%0.0%
Q3 2021$583,000
-2.0%
15,915
+5.1%
0.00%
-33.3%
Q2 2021$595,000
+31.1%
15,147
-5.8%
0.00%
+50.0%
Q1 2021$454,000
-12.2%
16,087
-0.3%
0.00%
-33.3%
Q4 2020$517,000
-1.1%
16,143
-0.3%
0.00%0.0%
Q3 2020$523,000
+42.9%
16,198
+22.1%
0.00%
+50.0%
Q2 2020$366,000
+44.7%
13,267
+31.3%
0.00%0.0%
Q4 2019$253,00010,1040.00%
Other shareholders
HUTCHISON CHINA MEDITECH LTD shareholders Q3 2020
NameSharesValueWeighting ↓
Zeal Asset Management Ltd 2,339,885$93,421,00021.31%
UG Investment Advisers Ltd. 33,155$1,302,0002.52%
Pinz Capital Management, LP 159,400$6,260,0001.88%
Capital International Sarl 547,743$21,510,0001.86%
Capital International, Inc./CA/ 4,391,684$172,461,0001.54%
AIA Group Ltd 437,118$17,380,0001.20%
York Capital Management Global Advisors, LLC 182,297$7,159,0000.80%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 68,000$2,671,0000.70%
E Fund Management (Hong Kong) Co., Ltd. 18,579$730,0000.46%
M&G INVESTMENT MANAGEMENT LTD 4,512,562$175,990,0000.44%
View complete list of HUTCHISON CHINA MEDITECH LTD shareholders